CryoPop Device to assess the safety and efficacy of in women with abnormal cervical cytology
Not Applicable
- Conditions
- Health Condition 1: 1- Obstetrics
- Registration Number
- CTRI/2019/01/017289
- Lead Sponsor
- ational Institute of Health and National Cancer Institute USA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. High-grade squamous intraepithelial lesion of the cervix (CIN 2/3), confirmed on histology
2. Eligible for cryotherapy based on size of lesion (occupies <75% of cervix) and fully visible on colposcopy or VIA
3. Willing and able to provide consent
Exclusion Criteria
1. Menopausal
2. History of hysterectomy
3. Known HIV+ or active cervical infections
4. Lesion occupies >75% of cervix and/or extends into the endo cervical canal
5. Pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method